HKU COVID-19 vaccine trials to start in July
Share - WeChat
A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- China releases survey report on coral reef ecosystem of Huangyan Island
- PLA strikes mobile ground targets in drills in middle areas of Taiwan Strait
- Legislation revised on spoken, written Chinese usage
- Amendment adds green focus for fishing industry
- Winter crayfish harvest secures year-round supply
- Death sparks discussion on solo living

































